Journal article
Cost‐effectiveness of formoterol and salbutamol as asthma reliever medication in Sweden and in Spain
Abstract
This study aimed to evaluate the cost-effectiveness of formoterol (Oxis) Turbuhaler 4.5 microg and salbutamol 200 microg as reliever medications in Sweden and Spain. The study used data on effectiveness (exacerbations and symptom-free days) and resource utilisation from an open, 6-month, parallel-group, multicentre randomised trial with 18,124 asthma patients in 24 countries. Country-specific unit costs for Sweden and for Spain were used to …
Authors
Lindgren B; Sears MR; Campbell M; Villasante C; Huang S; Lindh A; Petermann W; Svensson K; Berggren F; Pauwels RA
Journal
International Journal of Clinical Practice, Vol. 59, No. 1, pp. 62–68
Publisher
Hindawi
Publication Date
January 2005
DOI
10.1111/j.1742-1241.2005.00347.x
ISSN
1368-5031